| ViiV Healthcare GmbH - Tivicay 5 mg, Tabletten zur Herstellung einer Suspension zum Einnehmen | | 67861 | | 01 | | Tivicay 5 mg | | Tabletten zur Herstellung einer Suspension zum Einnehmen | | J05AJ03 | | | | 20.05.2021 | | |
| | Composition | | dolutegravirum 5 mg ut dolutegravirum natricum, mannitolum, cellulosum microcristallinum, povidonum K 29-32, carboxymethylamylum natricum A, cellulosum microcristallinum silicificatum, crospovidonum, calcii sulfas dihydricus, sucralosum, aromatica, natrii stearylis fumaras, Überzug: hypromellosum, macrogolum 400, E 171 pro compresso obducto corresp. natrium 0.45 mg. | | Packungsbestandteile | | Dispersible Tablets | | | | Active Agent | Dose |
|---|
| Dolutegravirum | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Aromatica | | | | Calcii Sulfas Dihydricus | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | Cellulosum Microcristallinum Silicificatum | | | | Crospovidonum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Mannitol | | | | Natrii Stearylis Fumaras | | | | Povidonum K | 29-32 | | | Pro Compresso Obducto | | | | Sucralosum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 60 | PR | PR | A | | Yes |
|
|
